Belvedere Trading LLC Tg Therapeutics, Inc. Transaction History

Belvedere Trading LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$8.36 - $26.5 $33,523 - $106,265	4,010 Added 133.22%	7,020 $58,000
Q2 2023 Aug 08, 2023	BUY	$15.48 - $35.0 $46,594 - $105,350	3,010 New	3,010 $74,000
Q4 2022 Feb 14, 2023	BUY	$5.01 - $11.83 $191,477 - $452,130	38,219 Added 575.41%	44,861 $530,000
Q3 2022 Oct 26, 2022	SELL	$4.57 - $8.4 $37,035 - $68,073	-8,104 Reduced 54.96%	6,642 $36,000
Q2 2022 Jul 21, 2022	SELL	$3.74 - $10.66 $7,839 - $22,343	-2,096 Reduced 12.45%	14,746 $93,000
Q1 2022 Apr 20, 2022	BUY	$7.81 - $20.45 $131,536 - $344,418	16,842 New	16,842 $122,000

336

87.6M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.23B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.